CORE
COnnecting
REpositories

    1 research outputs found

    Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30?Expressing Non-Hodgkin Lymphomas:Results of a Multicenter, Open-Labeled Phase II Trial

    Author
    Publication venue
    CANCER RESEARCH AND TREATMENT
    Publication date
    Field of study
    No full text
    University of Ulsan Open Access Korea
    corecore